SOL-1 is a superiority study being conducted under a Special Protocol Agreement (SPA) with the US Food and Drug ...

EyePoint Pharmaceuticals has dosed the first patient in the LUCIA Phase 3 trial of Duravyu for wet AMD. The study evaluates ...

Prevent Blindness announces its fourth annual Geographic Atrophy Awareness Week, December 2 to 8, 2024. The organization ...